• Novel Allosteric PDK4 Inhibitors for Metabolic Disease Thera

  2026-07-01

  Jeon et al. report the discovery and characterization of a new series of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, with compound 8c emerging as a promising candidate for oral treatment of metabolic diseases. The research demonstrates efficacy in models of diabetes, allergy, and cancer, highlighting mechanistic and translational relevance.

• Penicillin G Sodium: Reliable Solutions for Cell-Based Assay

  2026-06-30

  This article explores data-driven strategies for overcoming laboratory challenges in cell viability and cytotoxicity assays using Penicillin G Sodium (SKU B1678). Through scenario-based Q&A, it guides researchers in optimizing antibiotic selection, protocol design, and result interpretation. Harness the reproducibility and validated performance of Penicillin G Sodium for robust experimental outcomes.

• Adefovir-Induced Hypophosphatemic Osteochondrosis Mimicking

  2026-06-30

  This case study reveals how long-term adefovir therapy can induce hypophosphatemic osteochondrosis that closely mimics ankylosing spondylitis (AS) both clinically and radiographically. The findings underscore the importance of metabolic evaluation in patients on nucleotide analog antivirals who present with musculoskeletal symptoms, to avoid misdiagnosis and optimize patient management.

• Cabazitaxel (XRP6258): Technical Use in Resistant Tumor Mode

  2026-06-29

  Cabazitaxel (XRP6258) is a semi-synthetic taxane designed to address taxane resistance in cancer research, especially in P-glycoprotein-expressing cell lines. It is best suited for DMSO- or ethanol-based in vitro and in vivo protocols, but is unsuitable for aqueous systems or long-term solution storage.

• Phenothiazines Induce Macrophage Antibacterial Activity via

  2026-06-29

  The reference study establishes that phenothiazines, including perphenazine, significantly enhance the antibacterial capacity of macrophages by stimulating both reactive oxygen species (ROS) production and autophagy. These findings provide a mechanistic basis for host-directed antibacterial strategies, with implications for tackling antibiotic resistance and intracellular pathogens.

• EdU Flow Cytometry Assay Kits (Cy5): Mechanistic Innovation

  2026-06-28

  Explore the advanced mechanisms and novel biomarker applications enabled by EdU Flow Cytometry Assay Kits (Cy5). This article offers a deep scientific perspective on click chemistry DNA synthesis detection and its implications for cell cycle research, setting it apart from standard product guides.

• Vancomycin Hydrochloride Workflows: From Resistance Assays t

  2026-06-27

  Vancomycin hydrochloride stands as a gold-standard glycopeptide antibacterial agent for probing Gram-positive inhibition, resistance mechanisms, and animal infection models. This guide distills practical workflows, protocol optimizations, and troubleshooting essentials for researchers seeking robust, reproducible results.

• Phenothiazines Induce Macrophage Antibacterial Activity via

  2026-06-26

  This study reveals that phenothiazines, notably perphenazine, enhance the antibacterial functions of macrophages by stimulating autophagy and reactive oxygen species (ROS) production, highlighting a promising host-directed strategy against intracellular bacterial infections. The findings provide mechanistic insight into how dopamine D2 receptor antagonists can modulate innate immunity without inducing bacterial resistance.

• Phenothiazines Enhance Macrophage Antibacterial Activity via

  2026-06-26

  The reference study demonstrates that phenothiazines—including perphenazine—substantially boost macrophage antibacterial defense by inducing reactive oxygen species (ROS) and autophagy. These mechanisms represent a promising host-directed strategy to combat intracellular bacterial infections, especially in the context of rising antibiotic resistance.

• Ruxolitinib (INCB018424): Selective JAK1/2 Inhibitor for Mye

  2026-06-25

  Ruxolitinib (INCB018424) is a highly selective, ATP-competitive JAK1/2 kinase inhibitor widely used in myeloproliferative disorder and JAK-STAT pathway research. It demonstrates nanomolar potency, robust selectivity over JAK3, and dose-dependent inhibition of hematopoietic progenitor growth. This dossier summarizes its validated mechanisms, evidence benchmarks, and protocol integration, with a focus on reproducibility and translational relevance.

• Doxycycline Hyclate: Next-Gen MMP Inhibition in Translationa

  2026-06-25

  This thought-leadership article explores how Doxycycline hyclate, as a matrix metalloproteinases inhibitor, is redefining experimental approaches in neurovascular and translational research, with a focus on mechanistic insights, evidence-based protocols, and strategic guidance for researchers targeting blood-brain barrier dysfunction and cognitive impairment.

• NS1-Driven DNMT1 Degradation Regulates HBoV1 Replication

  2026-06-24

  This study reveals that the NS1 protein of human bocavirus 1 (HBoV1) promotes degradation of DNMT1, the principal DNA methyltransferase, to modulate viral DNA methylation and RNA processing. These findings identify a novel epigenetic regulatory mechanism in parvovirus replication and highlight DNMT1 as a promising antiviral target.

• Oligo (dT) 25 Beads: Technical Guidance for mRNA Purificatio

  2026-06-23

  Oligo (dT) 25 Beads enable efficient, selective isolation of eukaryotic mRNA via magnetic bead-based capture of polyadenylated transcripts. This product is optimized for workflows requiring high-purity mRNA from total RNA or tissue lysates, directly supporting cDNA synthesis and other downstream applications. It is not suitable for non-polyA RNA enrichment or workflows requiring long-term bead storage outside 4 °C.

• Stat3 Drives Fyn Kinase-Mediated Dopaminergic Neurodegenerat

  2026-06-23

  This study establishes Stat3 as a critical mediator linking Fyn kinase activation to dopaminergic neuron loss and microglial inflammation in a zebrafish neurodegeneration model. These insights clarify cell-type-specific mechanisms underlying Parkinson's disease risk and highlight new experimental pathways for functional gene studies.

• Vincristine sulfate (SKU A1765): Reliable Microtubule Disrup

  2026-06-22

  This article delivers a scenario-driven, evidence-based exploration of Vincristine sulfate (SKU A1765) for advanced cancer research workflows. It addresses common laboratory challenges—such as assay reproducibility, solubility optimization, and vendor reliability—and demonstrates how this microtubule disrupter from APExBIO provides robust, data-backed solutions for cell viability, proliferation, and cytotoxicity assays.

454 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page